![Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer | NEJM Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2002/nejm_2002.346.issue-2/nejmoa003034/production/images/img_medium/nejmoa003034_f2.jpeg)
Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer | NEJM
![Small Cell Lung Cancer: How to Improve Survival Rates - Small Cell Lung Cancer: Contemporary Concepts Small Cell Lung Cancer: How to Improve Survival Rates - Small Cell Lung Cancer: Contemporary Concepts](https://clf1.medpagetoday.com/assets/images/resource-center/lung%20tumors.jpg)
Small Cell Lung Cancer: How to Improve Survival Rates - Small Cell Lung Cancer: Contemporary Concepts
![Cureus | Case of Complete Remission from Palliative Radiation in Extensive Stage Small Cell Lung Cancer With Large Brain Metastasis Nine Years After Diagnosis: Cure Is Possible | Article Cureus | Case of Complete Remission from Palliative Radiation in Extensive Stage Small Cell Lung Cancer With Large Brain Metastasis Nine Years After Diagnosis: Cure Is Possible | Article](https://assets.cureus.com/uploads/figure/file/139734/lightbox_359fa170df1611eaaf4ffd4c2b2a33e4-Figure-1.png)
Cureus | Case of Complete Remission from Palliative Radiation in Extensive Stage Small Cell Lung Cancer With Large Brain Metastasis Nine Years After Diagnosis: Cure Is Possible | Article
![High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet Oncology High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/dbec891b-f83b-4e40-8287-f397533b9221/gr1.gif)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet Oncology
![Extensive-Stage Small Cell Lung Cancer (ESCLC) - Market Insight, Epidemiology and Market Forecast -2032 Extensive-Stage Small Cell Lung Cancer (ESCLC) - Market Insight, Epidemiology and Market Forecast -2032](http://www.researchandmarkets.com/product_images/12203/12203655_500px_jpg/extensivestage_small_cell_lung_cancer_market.jpg)
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Market Insight, Epidemiology and Market Forecast -2032
![Use of thoracic radiation therapy for small-cell lung cancer | Personalized Management of Lung Cancer Use of thoracic radiation therapy for small-cell lung cancer | Personalized Management of Lung Cancer](https://www.futuremedicine.com/cms/10.2217/ebo.12.157/asset/images/medium/figure2.gif)
Use of thoracic radiation therapy for small-cell lung cancer | Personalized Management of Lung Cancer
![Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study | BMC Cancer | Full Text Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-08082-2/MediaObjects/12885_2021_8082_Fig1_HTML.png)
Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study | BMC Cancer | Full Text
![Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India - ScienceDirect Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1110036216300590-gr4.jpg)
Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India - ScienceDirect
![Frontiers | First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis Frontiers | First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis](https://www.frontiersin.org/files/Articles/699781/fonc-11-699781-HTML/image_m/fonc-11-699781-g001.jpg)
Frontiers | First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis
![Overall survival in the A limited- and B extensive-stage small-cell... | Download Scientific Diagram Overall survival in the A limited- and B extensive-stage small-cell... | Download Scientific Diagram](https://www.researchgate.net/publication/358377458/figure/fig2/AS:1120318055821319@1644116047535/Overall-survival-in-the-A-limited-and-B-extensive-stage-small-cell-lung-cancer-groups.png)